Concepedia

Author

Francisco Pasquau

Hospital Marina Baixa

Also Known As

Concha Amador, F Pasquau, F. Pasquau, Francisco Pasquau, Reyes Pascual

43

Publications

774

Citations

14

H-Index

22

Concepts

All Affiliations

Hospital Marina BaixaInstituto Ramón y Cajal de Investigación SanitariaHospital Clínico San CarlosInstituto de Investigación Biosanitaria de GranadaHospital Universitario Ramón y Cajal
FP

About

Francisco Pasquau is an author at Hospital Marina Baixa specializing in hiv, medicine, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

270

2

Epidemiology

3

3

221

3

Health Sciences

1

1

35

4

Public Health

1

1

48

5

Hepatology

1

1

48

Francisco Pasquau

×

8

Publications

479

Citations

8

H-Index

YearCitations

Clinical characteristics and outcome of Spanish patients with ANCA-associated vasculitides

Roser Soláns-Laqué, G. Fraile, Mónica Rodríguez‐Carballeira,

Medicine

2017

151

Leishmaniasis as an opportunistic infection in HIV-infected patients: determinants of relapse and mortality in a collaborative study of 228 episodes in a Mediterreanean region

Francisco Pasquau, Javier Ena, Rafael Torregrosa Sánchez,

European Journal of Clinical Microbiology & Infectious Diseases

2005

105

Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study

Sergio Serrano‐Villar, Javier Martínez‐Sanz, Raquel Ron,

The Lancet HIV

2020

68

Risk and determinants of developing severe liver toxicity during therapy with nevirapine-and efavirenz-containing regimens in HIV-infected patients

Javier Ena, Concepción Benito, Vicenta Fenoll,

International Journal of STD & AIDS

2003

48

Once-a-Month Administration of Intravenous Pentamidine to Patients Infected with Human Immunodeficiency Virus as Prophylaxis for Pneumocystis carinii Pneumonia

Javier Ena, Concha Amador, Francisco Pasquau,

Clinical Infectious Diseases

1994

35

Expanding HIV clinical monitoring: the role of CD4, CD8, and CD4/CD8 ratio in predicting non-AIDS events

Javier Martínez‐Sanz, Jorge Díaz-Álvarez, Marta Rosas Cancio-Suárez,

EBioMedicine

2023

32

Effectiveness and tolerability of dolutegravir/lamivudine for the treatment of HIV-1 infection in clinical practice

Inés Suárez‐García, Belén Alejos, Víctoria Hernando,

Journal of Antimicrobial Chemotherapy

2023

26

Pharmacological and clinical evidence of nevirapine immediate- and extended-release formulations

Javier Ena, Conxa Benito, Francisco Pasquau

HIV/AIDS - Research and Palliative Care

2012

14

Page 1